KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024)

Ginkgo Bioworks Holdings' Acquisitions history spans 2 years, with the latest figure at $5.4 million for Q1 2024.

  • For Q1 2024, Acquisitions changed N/A year-over-year to $5.4 million; the TTM value through Dec 2024 reached $5.4 million, changed N/A, while the annual FY2024 figure was $5.4 million, N/A changed from the prior year.
  • Acquisitions reached $5.4 million in Q1 2024 per DNA's latest filing, up from -$9.3 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $20.2 million in Q3 2021 to a low of -$9.3 million in Q4 2021.